Kidney transplantation in Jerusalem, 1972-89. Kidney Transplant Group.
The results of a small transplant program over 18 years are presented. Two hundred and fifty-six transplantations including 36 living donor transplants were performed in 203 patients. Graft survival at 1, 3, 5 and 10 years without and with cyclosporin A treatment was 57%, 49%, 44%, 38%, and 71%, 69%, 58%, -% (respectively). Patient survival was 83%, 67%, 62%, 54%, and 92%, 90%, 68%, -% (respectively). Recent results with cyclosporin A treatment have shown further improvement. Analysis using the COX model shows that age under 30 years, lack of systemic disease, and the use of cyclosporin A and living donors all improved patient survival. More than 10- and 5-year survival was achieved in 78 and 103 patients, respectively, of whom 53 and 81 have good graft function. Local transplant policy and patient material are discussed.
Friedlaender
M M
MM
Nephrology Service, Hadassah University Hospital, Jerusalem, Israel.
D000293:Adolescent; D000328:Adult; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D006085:Graft Survival; D006801:Humans; D007557:Israel; D007585:Jews; D016030:Kidney Transplantation / Q000706:statistics & numerical data*; D008297:Male; D008875:Middle Aged; D015397:Program Evaluation; D013997:Time Factors; D014019:Tissue Donors; D016896:Treatment Outcome
D016572:Cyclosporine